Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNF | P01375 | 1/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | KRAS | P01116 | 1/20 | 0.30 |
| ▸ | HMOX2 | P30519 | 1/20 | 0.30 |
| ▸ | CRYZ | Q08257 | 1/20 | 0.30 |
| ▸ | VAT1 | Q99536 | 1/20 | 0.30 |
| ▸ | RTN4 | Q9NQC3 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25524049 | 0.81 | EGFR (0.36) | EGFRKRASHMOX2CRYZVAT1 | |
| SCHEMBL25524048 | 0.78 | IRAK4 (0.33) | TNFEGFR | |
| SCHEMBL25521670 | 0.71 | KRAS (0.36) | EGFRKRASHMOX2CRYZVAT1 | |
| SCHEMBL25521668 | 0.68 | EGFR (0.31) | TNFEGFR | |
| SCHEMBL25519676 | 0.66 | — | — | |
| SCHEMBL25083210 | 0.61 | EGFR (0.38) | EGFRKRASHMOX2CRYZVAT1 | |
| SCHEMBL22336561 | 0.61 | KRAS (0.53) | EGFRKRASHMOX2CRYZVAT1 | |
| SCHEMBL25777825 | 0.59 | KRAS (0.52) | EGFRKRASHMOX2CRYZVAT1 | |
| SCHEMBL18128619 | 0.59 | KRAS (0.44) | EGFRKRASHMOX2CRYZVAT1 | |
| SCHEMBL24037705 | 0.58 | KDR (0.41) | EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023086428-A2 | NOVEL MODULATORS OF THE ARYL HYDROCARBON RECEPTOR AND METHODS OF USE THEREOF | ALLIANTHERA (SUZHOU) BIOPHARMACEUTICAL CO., LTD. (CN) | 2023-05-19 | — | — | WO | disclosed |